breast cancer, which was published in January 2007 by Oxford University Press and titled False Hope: Bone Marrow Transplantation for Breast Cancer.

Jerry Avorn, M.D., is Professor of Medicine at Harvard Medical School and Chief of the Division of Pharmaco-epidemiology and Pharmaco-economics in the Department of Medicine at Brigham and Women’s Hospital. An internist, geriatrician, and drug epidemiologist, he studies the intended and adverse effects of drugs, physician prescribing practices, and medication policy. Dr. Avorn pioneered the “academic detailing” approach in which evidence-based information about drugs is provided to doctors through educational outreach programs run by noncommercial sponsors; such programs are now in widespread use throughout the United States, Canada, Australia, Europe, and the developing world. He completed his undergraduate training at Columbia University in 1969, received an M.D. from Harvard Medical School in 1974, and was a resident in internal medicine at the Beth Israel Hospital in Boston. He has served on several national and international panels as an expert on the determinants and consequences of medication use, and is a past President of the International Society of Pharmaco-Epidemiology. Dr. Avorn is the author of more than 200 papers in the medical literature on medication use and its outcomes, and he is one of the most highly cited researchers working in the area of medicine and the social sciences. His book, Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs, was published by Knopf in 2004 and re-issued in 2005.

Peter B. Bach, M.D., is Associate Attending Physician at Memorial Sloan-Kettering Cancer Center in New York and is board certified in internal medicine, pulmonary medicine, and critical care medicine. He is a National Institutes of Health-funded researcher with expertise in quality of care and epidemiologic research methods. His research on health disparities, variations in healthcare quality, and lung cancer epidemiology has appeared in The New England Journal of Medicine, the Journal of the American Medical Association, and the Journal of the National Cancer Institute. Bach served as a senior adviser to the Administrator of the Centers for Medicare & Medicaid Services from February 2005 through November 2006, where his work focused on improving evidence about the effect of therapies and devices and revising payment to enhance care quality. He was the agency lead on cancer policy. During the Rwandan Civil War, he was a camp physician in Goma, Zaire, caring for refugees. Bach received his bachelor’s degree in English and American Literature from Harvard College, his M.D. from the University of Minnesota, and his master’s degree in public policy from the University of Chicago, where he was also a Robert Wood Johnson

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement